Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Zepp Health (ZEPP) EBT (2016 - 2025)

Zepp Health has reported EBT over the past 10 years, most recently at -$1.9 million for Q4 2025.

  • For Q4 2025, EBT rose 71.24% year-over-year to -$1.9 million; the TTM value through Dec 2025 reached -$22.0 million, up 42.1%, while the annual FY2025 figure was -$35.5 million, 38.76% up from the prior year.
  • EBT for Q4 2025 was -$1.9 million at Zepp Health, down from $922000.0 in the prior quarter.
  • Over five years, EBT peaked at $13.4 million in Q2 2021 and troughed at -$22.3 million in Q1 2022.
  • A 5-year average of -$5.4 million and a median of -$7.0 million in 2022 define the central range for EBT.
  • Biggest five-year swings in EBT: skyrocketed 290.89% in 2021 and later crashed 362.54% in 2024.
  • Year by year, EBT stood at $4.3 million in 2021, then crashed by 270.66% to -$7.3 million in 2022, then soared by 139.48% to $2.9 million in 2023, then plummeted by 332.61% to -$6.7 million in 2024, then soared by 71.24% to -$1.9 million in 2025.
  • Business Quant data shows EBT for ZEPP at -$1.9 million in Q4 2025, $922000.0 in Q3 2025, and -$4.6 million in Q2 2025.